Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034191965> ?p ?o ?g. }
- W2034191965 endingPage "63" @default.
- W2034191965 startingPage "55" @default.
- W2034191965 abstract "Abstract Tipifarnib (T) exhibits modest activity in elderly adults with newly diagnosed acute myelogenous leukemia (AML). Based on preclinical synergy, a phase 1 trial of T plus etoposide (E) yielded 25% complete remission (CR). We selected 2 comparable dose levels for a randomized phase 2 trial in 84 adults (age range, 70-90 years; median, 76 years) who were not candidates for conventional chemotherapy. Arm A (T 600 mg twice a day × 14 days, E 100 mg days 1-3 and 8-10) and arm B (T 400 mg twice a day × 14 days, E 200 mg days 1-3 and 8-10) yielded similar CR, but arm B had greater toxicity. Total CR was 25%, day 30 death rate 7%. A 2-gene signature of high RASGRP1 and low aprataxin (APTX) expression previously predicted for T response. Assays using blasts from a subset of 40 patients treated with T plus E on this study showed that AMLs with a RASGRP1/APTX ratio of more than 5.2 had a 78% CR rate and negative predictive value 87%. This ratio did not correlate with outcome in 41 patients treated with conventional chemotherapies. The next T-based clinical trials will test the ability of the 2-gene signature to enrich for T responders prospectively. This study is registered at www.clinicaltrials.gov as #NCT00602771." @default.
- W2034191965 created "2016-06-24" @default.
- W2034191965 creator A5002639476 @default.
- W2034191965 creator A5006624449 @default.
- W2034191965 creator A5007068246 @default.
- W2034191965 creator A5010802811 @default.
- W2034191965 creator A5016810759 @default.
- W2034191965 creator A5017176608 @default.
- W2034191965 creator A5018531947 @default.
- W2034191965 creator A5022230035 @default.
- W2034191965 creator A5026776372 @default.
- W2034191965 creator A5027165899 @default.
- W2034191965 creator A5031631539 @default.
- W2034191965 creator A5040539933 @default.
- W2034191965 creator A5040758762 @default.
- W2034191965 creator A5052920087 @default.
- W2034191965 creator A5054370710 @default.
- W2034191965 creator A5059680271 @default.
- W2034191965 creator A5060944483 @default.
- W2034191965 creator A5071498000 @default.
- W2034191965 creator A5078527108 @default.
- W2034191965 creator A5078887304 @default.
- W2034191965 creator A5079274832 @default.
- W2034191965 creator A5088671320 @default.
- W2034191965 creator A5089694123 @default.
- W2034191965 date "2012-01-05" @default.
- W2034191965 modified "2023-09-28" @default.
- W2034191965 title "Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia" @default.
- W2034191965 cites W141365462 @default.
- W2034191965 cites W1556454749 @default.
- W2034191965 cites W1955547739 @default.
- W2034191965 cites W1968355594 @default.
- W2034191965 cites W1973097976 @default.
- W2034191965 cites W1974740049 @default.
- W2034191965 cites W1980624390 @default.
- W2034191965 cites W1986603272 @default.
- W2034191965 cites W1996708547 @default.
- W2034191965 cites W2010269862 @default.
- W2034191965 cites W2014532100 @default.
- W2034191965 cites W2025754007 @default.
- W2034191965 cites W2034295250 @default.
- W2034191965 cites W2051987542 @default.
- W2034191965 cites W2064293764 @default.
- W2034191965 cites W2066812263 @default.
- W2034191965 cites W2068556430 @default.
- W2034191965 cites W2077777928 @default.
- W2034191965 cites W2081391009 @default.
- W2034191965 cites W2087607698 @default.
- W2034191965 cites W2094358576 @default.
- W2034191965 cites W2101515818 @default.
- W2034191965 cites W2102901804 @default.
- W2034191965 cites W2107029748 @default.
- W2034191965 cites W2107277218 @default.
- W2034191965 cites W2107398329 @default.
- W2034191965 cites W2109065151 @default.
- W2034191965 cites W2122756958 @default.
- W2034191965 cites W2126572589 @default.
- W2034191965 cites W2157287007 @default.
- W2034191965 cites W2159507916 @default.
- W2034191965 cites W2160553642 @default.
- W2034191965 cites W2160968219 @default.
- W2034191965 cites W2162700652 @default.
- W2034191965 cites W2171116665 @default.
- W2034191965 cites W4231404455 @default.
- W2034191965 cites W4239576136 @default.
- W2034191965 cites W4376595466 @default.
- W2034191965 doi "https://doi.org/10.1182/blood-2011-08-370825" @default.
- W2034191965 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3251236" @default.
- W2034191965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22001391" @default.
- W2034191965 hasPublicationYear "2012" @default.
- W2034191965 type Work @default.
- W2034191965 sameAs 2034191965 @default.
- W2034191965 citedByCount "25" @default.
- W2034191965 countsByYear W20341919652012 @default.
- W2034191965 countsByYear W20341919652013 @default.
- W2034191965 countsByYear W20341919652014 @default.
- W2034191965 countsByYear W20341919652015 @default.
- W2034191965 countsByYear W20341919652016 @default.
- W2034191965 countsByYear W20341919652017 @default.
- W2034191965 countsByYear W20341919652018 @default.
- W2034191965 countsByYear W20341919652020 @default.
- W2034191965 countsByYear W20341919652021 @default.
- W2034191965 crossrefType "journal-article" @default.
- W2034191965 hasAuthorship W2034191965A5002639476 @default.
- W2034191965 hasAuthorship W2034191965A5006624449 @default.
- W2034191965 hasAuthorship W2034191965A5007068246 @default.
- W2034191965 hasAuthorship W2034191965A5010802811 @default.
- W2034191965 hasAuthorship W2034191965A5016810759 @default.
- W2034191965 hasAuthorship W2034191965A5017176608 @default.
- W2034191965 hasAuthorship W2034191965A5018531947 @default.
- W2034191965 hasAuthorship W2034191965A5022230035 @default.
- W2034191965 hasAuthorship W2034191965A5026776372 @default.
- W2034191965 hasAuthorship W2034191965A5027165899 @default.
- W2034191965 hasAuthorship W2034191965A5031631539 @default.
- W2034191965 hasAuthorship W2034191965A5040539933 @default.
- W2034191965 hasAuthorship W2034191965A5040758762 @default.
- W2034191965 hasAuthorship W2034191965A5052920087 @default.
- W2034191965 hasAuthorship W2034191965A5054370710 @default.